期刊文献+

探讨降钙素原在治疗脓毒症患者中的意义 被引量:12

The significance of procalcitonin in the treatment of sepsis
下载PDF
导出
摘要 目的探讨脓毒症患者治疗中用降钙素原(PCT)水平来指导临床抗生素使用的意义。方法 60例脓毒症患者分为对照组与治疗组。对照组按常规治疗方法使用抗生素进行治疗,治疗组通过检测血清PCT浓度来指导抗生素使用。比较两组患者炎性指标:PCT治疗前后之间的差异及两组治疗抗生素使用时间费用及入住重症监护病房(ICU)时间的差异。结果两组经治疗后,治疗组抗生素使用天数、费用及入住ICU时间均明显低于对照组,差异有统计学意义(t=8.37,6.27,7.24,P<0.05)。结论脓毒症患者治疗中采用PCT浓度水平用药可以取得更好的治疗结果,减少入住ICU时间,减轻患者经济负担,值得临床推广。 ObjectiveTo investigate the significance of the level of procalcitonin(PCT)to guide the use of antibiotics in the treatment of sepsis.MethodsSixty patients with sepsis were randomly assigned into control group and PCT treatment group.The control group received routine treatment using antibiotic treatment while PCT group guided the use of antibiotics by detecting serum PCT concentration.Inflammatory indexes between the two groups were compared:PCT differences between before and after treatment,antibiotic treatment time and intensive care unit(ICU)time cost.ResultsAfter treatment,in the treatment group antibiotics use,cost,and duration of stay in ICU were significantly lower than those in the control group;the differences were statistically significant(t=8.37,6.27,724,respectively,P<0.05).ConclusionsSepsis patients were treated according to PCT levels,which can achieve better drug treatment effects,reduce the ICU admission time and the economic burden of patients.It was worthy of clinical application.
作者 田现民 TIAN Xianmin(Department of Emergency,The People's Hospital of Hebi City,Hebi,Henan458030,China)
出处 《安徽医药》 CAS 2017年第12期2257-2259,共3页 Anhui Medical and Pharmaceutical Journal
关键词 脓毒症 降钙素原 抗生素治疗 Sepsis Procalcitonin Antibiotic therapy
  • 相关文献

参考文献10

二级参考文献86

  • 1王瑞兰,许建宁,盛志勇,傅华群.机械通气动态通气参数对急性呼吸窘迫综合征犬肺损伤的影响[J].中国危重病急救医学,2006,18(6):334-337. 被引量:8
  • 2王晓芝,吕长俊,高福全,李笑宏,颜卫峰,宁方玉.目标指导下治疗脓毒性休克的疗效观察[J].中国危重病急救医学,2006,18(11):661-664. 被引量:13
  • 3Sessler CN, Shepherd W. New concepts in sepsis[J].Curr Opin Crit Care,2002,8(5):465-472.
  • 4Schwarz S, Bertram M, Schwab S, et al. Serum procalcitonin levels in bacterial and abacterial meningitis [J]. Crit Care Med, 2000,28(6) : 1828-1832.
  • 5Pettila V, Hynninen M, Takkunen O, et al. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis[J]. Intensive Care Med, 2002,28(9) : 1220- 1225.
  • 6Vincent JL. Procalcitonin: The marker of sepsis? [J].Crit Care Med,2000,28(4) : 1226-1228.
  • 7Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection[J].Lancet, 1993,341 (8844) :515-518.
  • 8Oberhoff M, Stonans I, Russwurm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro[J].J Lab Clin Med, 1999,134( 1 ) : 49-55.
  • 9Nylen ES, Whang KT, Snider RHJc, et al. Mortality is increased by procalcitonin and decreased by an antiserum reac rive to procalcitonin in experimental sepsis [J]. Crit Care Med,1998,26(9): 1001-1006.
  • 10Whang KT, Vath SD, Becker KL, et al. Procalcitonin and proinflammatory cytokine interaction in sepsis [J]. Shock, 2000,14( 1 ) : 73-78.

共引文献924

同被引文献100

引证文献12

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部